CI
AXA

Corient IA’s AXA ADS (1 ORD SHS) AXA Stock Holding History

Corient IA’s Portfolio AXA Stock Details AXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$491K – 296
2025
Q2 		$491K Hold
10,000
– – 0.29% 122
2025
Q1 		$426K Buy
+10,000
New +$426K 0.3% 127

Other funds holding AXA

BCAM
Boston Common Asset Management Boston, Massachusetts $1.55B AUM 14.69% 1-Year Est. Return
ACM
Altrius Capital Management New Bern, North Carolina $503M AUM 19.46% 1-Year Est. Return
RAM
Ramirez Asset Management New York $832M AUM 33.23% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
ACM
Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
RCM
RNC Capital Management Los Angeles, California $2.2B AUM 22.93% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PAM
Paradigm Asset Management New York $426M AUM 18.16% 1-Year Est. Return

Corient IA's AXA Position: Q3 2025 in Review

Corient IA sold out of AXA ADS (1 ORD SHS) (AXA) in Q3 2025, closing a stake of 10,000 shares — an estimated $491K sold.

Corient IA first reported a position in AXA in Q1 2025 and held it in 2 quarters. The position peaked at $491K in Q2 2025. 18 funds tracked by Wall St. Rank hold AXA as of Q3 2025.

  • Corient IA reported no remaining AXA ADS (1 ORD SHS) position as of Q3 2025 after selling out during the quarter.
  • Corient IA sold 10,000 AXA ADS (1 ORD SHS) shares in Q3 2025, an estimated $491K.
  • Corient IA first reported a position in AXA ADS (1 ORD SHS) in Q1 2025 and held it in 2 quarters.
  • Corient IA's AXA ADS (1 ORD SHS) position peaked at $491K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held AXA ADS (1 ORD SHS) as of Q3 2025.

Based on Corient IA's 13F filing for Q3 2025, filed 12 Nov 2025.